Nektar Therapeutics
NKTR
NKTR
387 hedge funds and large institutions have $9.73B invested in Nektar Therapeutics in 2018 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 177 increasing their positions, 107 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
387
Holders Change
+10
Holders Change %
+2.65%
% of All Funds
8.86%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
55
Increased
177
Reduced
107
Closed
41
Calls
$225M
Puts
$155M
Net Calls
+$69.7M
Net Calls Change
+$31.9M
Top Buyers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$80.5M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$53.9M |
| 3 |
Capital Fund Management (CFM)
Paris,
France
|
+$43.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$37.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$109M |
| 2 |
Primecap Management
Pasadena,
California
|
-$45.6M |
| 3 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$42.6M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$39.3M |
| 5 |
Millennium Management
New York
|
-$37.8M |
